Blumberg B S, Larouzé B, London W T, Werner B, Hesser J E, Millman I, Saimot G, Payet M
Leber Magen Darm. 1976 Dec;6(6):309-15.
In Asia, Africa and other tropical areas primary hepatic carcinoma (PHC) is associated with liver cirrhosis of the post-necrotic (macronodular) type. Chronic viral hepatitis is likely to be the cause of this cirrhosis in many patients from regions where chronic infection with the hepatitis B virus (HBV) is common. More than 95% of patients with hepatoma (in Mali and Senegal) have evidence of infection with HBV, a much higher frequency than in controls. Thirty-nine of 62 PHC patients had hepatitis B surface antigen (HBSAg) (controls: 8 of 98) and 56 of 63 (controls: 26 of 100) had antibody against hepatitis B core antigen (anti-HBC). In earlier studies we demonstrated a maternal effect of HBSAg. If the mother has the antigen and the father does not, the children are much more likely to also have HBSAg than if the father has the antigen and the mother does not (93/161 = 57.8% when mother is positive vs. 28/135 = 20.7% when father is positive; p = 0.6 X 10(-10)). Studies in Greece and in the Solomon Islands show that presence of HBSAg in parents affects the sex ratio of the offspring of the mating. This implies that the presence of the agent in a parent can affect the fetus early in life. Parental studies in the African hepatoma patients showed that there is a very high frequency of HBSAg in mothers (71.6%) while the frequency in fathers (18.5%) is significantly less. This suggests that the development of hepatoma in offspring is related to infection in parents. We described a vaccine several years ago which may be useful in preventing infection with hepatitis B. Strategies are discussed which might be effective in preventing the development of carriers with, it is hoped, a consequent decrease in the frequency of HBV carriers, chronic hepatitis and primary hepatic carcinoma. The strategy would employ methods for decreasing the frequency of the agent in the environment by the application of public health methods including the vaccination of appropriate newborns and other members of the population.
在亚洲、非洲及其他热带地区,原发性肝癌(PHC)与坏死后(大结节性)肝硬化有关。在慢性乙型肝炎病毒(HBV)感染常见的地区,许多患者的这种肝硬化可能由慢性病毒性肝炎引起。(在马里和塞内加尔)超过95%的肝癌患者有HBV感染证据,这一频率远高于对照组。62例原发性肝癌患者中有39例乙肝表面抗原(HBSAg)呈阳性(对照组:98例中有8例),63例中有56例(对照组:100例中有26例)乙肝核心抗体(抗-HBC)呈阳性。在早期研究中,我们证明了HBSAg的母体效应。如果母亲有该抗原而父亲没有,孩子比父亲有抗原而母亲没有时更有可能也有HBSAg(母亲阳性时为93/161 = 57.8%,父亲阳性时为28/135 = 20.7%;p = 0.6×10⁻¹⁰)。希腊和所罗门群岛的研究表明,父母体内HBSAg的存在会影响配偶后代的性别比例。这意味着父母体内存在该病原体可在生命早期影响胎儿。对非洲肝癌患者的父母研究表明,母亲中HBSAg的频率非常高(71.6%),而父亲中的频率(18.5%)明显较低。这表明后代肝癌的发生与父母感染有关。几年前我们描述了一种可能有助于预防乙肝感染的疫苗。讨论了一些策略,希望这些策略能有效预防携带者的产生,从而降低HBV携带者、慢性肝炎和原发性肝癌的发病率。该策略将采用公共卫生方法,包括对适当的新生儿和其他人群进行疫苗接种,以降低环境中病原体的频率。